Small molecule nerve growth factor analogs image receptors in vivo

Nature Biotechnology

Volumn 14, Issue 9, 1996, Pages 1120-1123

  Lesauteur, Lynne ^a   Cheung, Nai Kong V ^c   Lisbona, Robert ^d   Uri Saragovi, H ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Analog; Imaging; Mimic; NGF receptor; TrkA

Indexed keywords

EID: 0029781321     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0996-1120     Document Type: Article

References (22)

1. 99mTc-protein conjugates. Bioconjugate Chemistry 2:333-336.
2. Saragovi, H.U. and Greene, M.I. 1992. Constrained peptides and mimetics as probes of protein secondary structure. Immunomethods 1:3-12.
3. Zhang, X., Piatier-Tonneau, D., Auffray, C, Murali, P., Mahapatra, A., Zhang, R, et al. 1996. Synthetic CD4 exocyclic peptides antagonize CD4 holoreceptor binding and T cell activation. Nature Biotechnology 14:472-475.
4. Barbacid, M. 1994. The Trk family of neurotrophin receptors. J. Neurobiol. 25:1386-1403.
5. Nakagawara, A., Arima-Nakagawara, M., Scavarda, N.J., Azar, C.G., Cantor, A.B., and Brodeur, G.M. 1993. Association between high levels of expression of the Trk gene and favorable outcome in human neuroblastoma. N. Engl. J. of Med. 328:847-854.
6. Oelman, E., Sreter, L, Schuller, I., Serve, H., Uoenigsann, M., Wiedmann, B., et al. 1995. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high affinity nerve growth factor binding sites involving tyrosine kinase signalling. Cancer Res. 55:2212-2219.
7. Marchetti, D., Menter, D., Jin, L, Nakajima, M„ and Nicolson, G.L 1993. Nerve growth factor effects on human and mouse melanoma cell invasion and hepa-ranase production. Intl. J. Cancer 55:692-699.
8. LeSauteur, L, Wei, L, Gibbs, B., and Saragovi, H.U. 1995. Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J. Biol. Chem. 270:6564-6569.
9. LeSauteur, L, Wei, L, Gibbs, B., and Saragovi, H.U. 1996. Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses (addition and correction). J. Biol. Chem. 271:1249.
10. LeSauteur, L., Maliartchouk, S., LeJeune, H., Quirion, R., and Saragovi, H.U. 1996. Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody. J. Neurosci. 16:1308-1316.
11. Jing, S., Tapley, P., and Barbacid, M. 1992. Nerve growth factor mediates signal transduction through Trk homodimer receptors. Neuron 9:1067-1079.
12. Yasumura, Y, Buonsassisi, V., and Sato, G. 1966. Clonal analysis of differentiated function in animal cell cultures. I. Possible correlated maintenance of differentiated function and the diploid karyotype. Cancer Res. 26:529-535.
13. Michitsch, R.W., Biedler, J.L., and Melera, P.W. 1988. Modulation of N-myc expression, but not tumorigenicity, accompanies phenotypic conversion of neuroblastoma cells in prolonged culture, pp. 103-120 in Advances in neuroblastoma research 2. Evans, A.E., D’Angio, G.J., Knudson, A.G., and Seeger, R.C. (eds.). Progress in clinical and biological research. Vol 271. Alan R. Liss, Inc, NY.
14. Fujimori, K., Fisher, D.R., and Weinstein, J.N. 1991. Integrated microscopic/macroscopic pharmacology of monoclonal antibody radioconjugates: the radiation dose distribution. Cancer Res. 51:4821-4827.
15. Lomen-Hoerth, C. and Shooter, E.M. 1995. Widespread neurotrophin receptor expression in the immune system and other non-neuronal rat tissues. J. Neurochem. 64:1780-1789.
16. Esteban, I., Hannestad, J., Levanti, B., DelValle, M.E., Naves, F.J., and Vega, J.A. 1995. Neurotrophin receptor proteins immunoreactivity in human gastrointestinal endocrine cells. Brain Res. Bulletin 38:539-543.
17. Trail, P.A., Willner, D., Lasch, S.J., Henderson, A.J., Hofstead, S., Casazza, A.M., et al. 1993. Cure of xenografted human carcinomas by BR96-doxorubicin Immunoconjugates. Science 261:212-215.
18. Cheung, N.K., Kushner, B.H., Yeh, S.J., and Larson S.M. 1994. 3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study. Progress in Clinical and Biological Research 385:319-338.
19. Saragovi, H.U., Fitzpatrick, D., Raktabutr, A., Nakanishi, H., Kahn, M., and Greene, M.I. 1991. Design and synthesis of a mimetic from an antibody complementarity-determining region. Science 253:792-795.
20. Saragovi, H.U., Greene, M.I., Chrusciel, R.A., and Kahn, M. 1992. Loops and secondary structure mimetics: development and applications in basic science and rational drug design. Bio/Technology 10:773-778.
21. Kramer, K., Gerald, W., LeSauteur, L, Saragovi, H.U., and Cheung, N.-K.V. 1996. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma. Clin. Cancer Res. In press.
22. King, TP., Zhao, S.W., and Lam, T. 1986. Preparation of protein conjugates via intermolecular hydrazone linkage. Biochemistry 25:5774-5779.